OCULAR THERAPEUTIX, INC
For the period ended Dec 31, 2025. Filed Feb 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
| Item 2. | Properties |
|---|
Our facilities consist of leased office space, laboratory space and manufacturing facilities. Effective January 1, 2026, we entered into a sublease for approximately 24,000 square feet of office space located at 14 Crosby Drive in Bedford, Massachusetts. The lease commenced on January 1, 2026 and will expire on March 30, 2031. We expect this location will become our company headquarters. A summary of our leased properties is as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| Location | | ApproximateSquare Feet | | Use | | LeaseExpiration |
| Bedford, MA | | 71,000 | | Manufacturing, laboratories, warehouse, office space | | 2027 |
| Bedford, MA | | 24,000 | | Office space (future corporate headquarters) | | 2031 |
| Bedford, MA | | 20,000 | | Manufacturing, warehouse, office space | | 2028 |
We hold options to extend the lease for approximately 71,000 square feet in Bedford, Massachusetts for a total of up to 10 additional years. We believe our current facilities are suitable and adequate to meet our current needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.